AP2419A - Orally administrable antimalarial combined preparation and preparation process thereof. - Google Patents

Orally administrable antimalarial combined preparation and preparation process thereof.

Info

Publication number
AP2419A
AP2419A AP2005003402A AP2005003402A AP2419A AP 2419 A AP2419 A AP 2419A AP 2005003402 A AP2005003402 A AP 2005003402A AP 2005003402 A AP2005003402 A AP 2005003402A AP 2419 A AP2419 A AP 2419A
Authority
AP
ARIPO
Prior art keywords
preparation
antimalarial
orally administrable
combined
preparation process
Prior art date
Application number
AP2005003402A
Other languages
English (en)
Inventor
Sung Tae Lee
Woo-Yle Park
Jeong-Ryul Noh
Original Assignee
Shin Poong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co Ltd filed Critical Shin Poong Pharmaceutical Co Ltd
Application granted granted Critical
Publication of AP2419A publication Critical patent/AP2419A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
AP2005003402A 2004-11-02 2005-09-29 Orally administrable antimalarial combined preparation and preparation process thereof. AP2419A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040088413A KR100623322B1 (ko) 2004-11-02 2004-11-02 경구투여용 항말라리아 배합 제제 및 그의 제조방법

Publications (1)

Publication Number Publication Date
AP2419A true AP2419A (en) 2012-06-05

Family

ID=36319369

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003402A AP2419A (en) 2004-11-02 2005-09-29 Orally administrable antimalarial combined preparation and preparation process thereof.

Country Status (8)

Country Link
KR (1) KR100623322B1 (xx)
CN (1) CN101052392B (xx)
AP (1) AP2419A (xx)
BR (1) BRPI0517241B8 (xx)
HK (1) HK1113079A1 (xx)
OA (1) OA13155A (xx)
WO (1) WO2006049391A1 (xx)
ZA (1) ZA200703467B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101544638B (zh) * 2009-05-12 2012-05-30 重庆通天药业有限公司 乳酸咯萘啶及其药物组合物
CN109640993B (zh) 2016-08-12 2021-07-09 诺麦塔制药有限公司 包含阿莫地喹及抗糖尿病药物作为有效成分的用于预防或治疗糖尿病的药学组合物
JP2023519277A (ja) * 2020-03-26 2023-05-10 シンプン・ファーマシューティカル・カンパニー・リミテッド 伝染性ｒｎａウイルス感染症の予防又は治療するための医薬組成物
CN113350334A (zh) * 2021-02-05 2021-09-07 中国中医科学院中药研究所 一种含有双氢青蒿素的抗疟药物
WO2022231238A1 (ko) * 2021-04-26 2022-11-03 심민보 아르테수네이트 또는 그의 염, 및 피로나리딘 또는 그의 염의 해열, 항염증, 항바이러스용, 또는 covid-19 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법
KR20230076573A (ko) 2021-11-24 2023-05-31 장은혜 야생쑥 추출 천연 아르테미시닌을 함유한 항말라리아용 구강붕해성 필름제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1200925A (zh) * 1997-05-30 1998-12-09 北京市科泰新技术公司 一种治疗抗药性恶性疟疾的药物组合物及其制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIU ET AL: 'Study on treatment of multi-drug resistant falciparum malaria by using a combination of dihydroartemisinin and pyronaridine' ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BING ZA ZHI vol. 20, no. 4, 2002, pages 193 - 196 *
YANG ET AL: 'Effect of pyronaridine, mefloquine and quinine on artesunate-sensitive and artesunate resistant Plasmodium falciparum' ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BANG ZA ZHI vol. 18, no. 1, 2000, pages 5 - 7 *
ZHANG ET AL: 'Studies on the establishment of malarial animal model of short-term relapse. III. Combined therapy with pyronaridine-artemether-chloroquine for parasitemia clearance' ZHONGGUO JI SHENG CHONG XUE YU JI SHENG CHONG BING ZA ZHI vol. 11, no. 3, 1993, pages 180 - 184 *

Also Published As

Publication number Publication date
BRPI0517241A (pt) 2008-10-07
BRPI0517241B1 (pt) 2019-10-22
WO2006049391A1 (en) 2006-05-11
KR20060039286A (ko) 2006-05-08
BRPI0517241B8 (pt) 2021-05-25
HK1113079A1 (en) 2008-09-26
OA13155A (en) 2006-12-13
ZA200703467B (en) 2008-09-25
CN101052392B (zh) 2010-12-15
CN101052392A (zh) 2007-10-10
KR100623322B1 (ko) 2006-09-19

Similar Documents

Publication Publication Date Title
IL175338A0 (en) Orally administrable films and preparation thereof
EP1747775A4 (en) DISPERSIBLE MONTMORILLONITE TABLET AND ITS MANUFACTURE
IL180706A0 (en) Pharmaceutical dosage forms including rasagiline
ZA200704661B (en) Solid, orally appliance pharmaceutical administration forms containing rivaroxaban having modified release
FI1765303T4 (fi) Väärinkäytöltä suojattu oraalinen tabletti
AP2255A (en) Irinotecan preparation.
EP1803446A4 (en) MOUTH-CATCHING TABLET AND MANUFACTURING PROCESS
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
IL228730A0 (en) Pharmaceutical manufacturing process
EP1731139A4 (en) PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
AP2419A (en) Orally administrable antimalarial combined preparation and preparation process thereof.
HK1113686A1 (en) Biotinylated hexadecasaccharides, preparation and use thereof
HK1105872A1 (en) Orally dispersible pharmaceutical composition and process for the preparation thereof
AP2006003557A0 (en) Antimalarial compositions and process thereof.
GB0424323D0 (en) Tablet
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
ZA200704714B (en) Integrated separation and preparation process
IL177759A0 (en) Cospeptin, cosmedin and their uses
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
GB2418628B (en) Improved laminates and the manufacture thereof
EP1781678A4 (en) 1 -? - HALOGEN-2,2-DIFLUOR-2-DESOXY-D-RIBOFURANOSEDERIVATE AND PROCESS FOR THE PRODUCTION THEREOF
EP1716865A4 (en) PHARMACEUTICAL PREPARATION CONTAINING PARAOXONASE
GB0408535D0 (en) Insoluble drugs
AU2004906975A0 (en) Daily dosage checker
AU2004902251A0 (en) Reminder RX